Resilient FY22/1H23 despite industry headwinds
石四药集团:强劲的1H22结果;但FY22E指引略低
FY22收入8.84亿人民币,调后净利0.98亿派息率50%
Nayuki Holdings Limited (2150 HK) 期待 FY22E 的数字化
FY22 net margins better than expected
FY22业绩不及预期;零售能力强化
Yalla(YALA)4Q22&FY22业绩会纪要–20230314
FY22E preview; Bumpy recovery in 2023
Outperforming FY22E, promising FY23E and not-far-fetching FY25E target
Hopson: weaker but much better than peers FY22